$40.00
5-Amino-1MQ (5-amino-1-methylquinolinium) is a small molecule, not a peptide. It is a membrane permeable, substrate site directed inhibitor of nicotinamide N-methyltransferase (NNMT), the cytosolic enzyme that transfers a methyl group from S-adenosyl-L-methionine to nicotinamide. It is used in metabolic research as a chemical tool for inhibiting NNMT in cell and rodent studies.
5-Amino-1-methylquinolinium (5-Amino-1MQ) is a synthetic small molecule. It is not a peptide, and it is listed alongside the peptide catalogue only because it is used in the same areas of metabolic research. It inhibits nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme that uses S-adenosyl-L-methionine as the methyl donor to methylate nicotinamide, producing 1-methylnicotinamide. NNMT is expressed in white adipose tissue and liver, and because nicotinamide is also the substrate for NAD+ resynthesis through the salvage pathway, NNMT activity is studied as one route by which nicotinamide is diverted away from that pathway.
5-Amino-1MQ is not an approved medicine in Canada, the United States or elsewhere. It is a research chemical with no marketing authorization anywhere, and it is not supplied for any medical purpose.
This compound is supplied and catalogued in two related forms, and the identifiers differ between them. Check which form your certificate of analysis describes before weighing out.
The most cited primary study is Neelakantan and colleagues, Biochemical Pharmacology 2018 (volume 147, pages 141 to 152). Findings below are reported at the evidence level the authors used:
Every batch of 5-Amino-1MQ undergoes:
HPLC and mass spectrometry characterize chemical purity and identity. They do not measure biological activity, and no potency testing is performed or implied.
For laboratory research use only. Not for human or veterinary use.
Further reading